Insulet Total Assets 2007-2019 | PODD

Insulet total assets from 2007 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Insulet total assets for the quarter ending June 30, 2019 were $0.978B, a 16.55% increase year-over-year.
  • Insulet total assets for 2018 were $0.929B, a 13.71% increase from 2017.
  • Insulet total assets for 2017 were $0.817B, a 78.86% increase from 2016.
  • Insulet total assets for 2016 were $0.457B, a 65.98% increase from 2015.
Insulet Annual Total Assets
(Millions of US $)
2018 $929
2017 $817
2016 $457
2015 $275
2014 $297
2013 $288
2012 $198
2011 $221
2010 $156
2009 $173
2008 $108
2007 $131
2006 $57
2005 $0
Insulet Quarterly Total Assets
(Millions of US $)
Q2 2019 $978
Q1 2019 $953
Q4 2018 $929
Q3 2018 $886
Q2 2018 $839
Q1 2018 $830
Q4 2017 $817
Q3 2017 $500
Q2 2017 $459
Q1 2017 $445
Q4 2016 $457
Q3 2016 $453
Q2 2016 $263
Q1 2016 $255
Q4 2015 $275
Q3 2015 $293
Q2 2015 $300
Q1 2015 $306
Q4 2014 $297
Q3 2014 $301
Q2 2014 $325
Q1 2014 $289
Q4 2013 $288
Q3 2013 $289
Q2 2013 $286
Q1 2013 $281
Q4 2012 $198
Q3 2012 $203
Q2 2012 $204
Q1 2012 $216
Q4 2011 $221
Q3 2011 $216
Q2 2011 $226
Q1 2011 $149
Q4 2010 $156
Q3 2010 $150
Q2 2010 $162
Q1 2010 $159
Q4 2009 $173
Q3 2009 $117
Q2 2009 $99
Q1 2009 $120
Q4 2008 $108
Q3 2008 $135
Q2 2008 $155
Q1 2008 $116
Q4 2007 $131
Q3 2007 $136
Q2 2007 $149
Q1 2007 $48
Q4 2006 $57
Q3 2006 $0
Q2 2006 $0
Q1 2006 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.336B $0.564B
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.122B 20.23
Abbott Laboratories (ABT) United States $141.639B 26.63
Stryker (SYK) United States $79.044B 27.33
Boston Scientific (BSX) United States $52.905B 25.66
Baxter (BAX) United States $44.730B 27.12
EssilorLuxottica Societe Anonyme (ESLOY) France $31.899B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.527B 17.62
Coloplast (CLPBY) Denmark $24.516B 39.14
Lonza Group Ag (LZAGY) Switzerland $24.500B 0.00
Terumo (TRUMY) Japan $23.332B 26.83
Smith & Nephew SNATS (SNN) United Kingdom $20.451B 0.00
ResMed (RMD) United States $18.758B 35.74
Sunny Optical Technology (SNPTF) China $16.343B 0.00
Bio-Rad Laboratories (BIO) United States $9.664B 51.80
Canopy Growth (CGC) Canada $7.103B 0.00
Perrigo (PRGO) Ireland $7.075B 13.03
Hill-Rom Holdings (HRC) United States $6.550B 19.53
Haemonetics (HAE) United States $6.367B 48.05
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.796B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.645B 0.00
Neogen (NEOG) United States $3.284B 54.96
NuVasive (NUVA) United States $3.263B 26.01
ICU Medical (ICUI) United States $3.151B 20.44
Quidel (QDEL) United States $2.356B 23.39
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.303B 0.00
Agios Pharmaceuticals (AGIO) United States $1.869B 0.00
National Vision Holdings (EYE) United States $1.827B 39.44
Cardiovascular Systems (CSII) United States $1.586B 0.00
Aphria (APHA) $1.164B 0.00
VAREX IMAGING (VREX) United States $1.064B 24.53
AtriCure (ATRC) United States $0.978B 0.00
Phibro Animal Health (PAHC) United States $0.849B 13.81
Eagle Pharmaceuticals (EGRX) United States $0.823B 20.97
Omeros (OMER) United States $0.745B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
PetIQ (PETQ) United States $0.722B 17.07
Lantheus Holdings (LNTH) United States $0.721B 18.96
Cerus (CERS) United States $0.623B 0.00
LeMaitre Vascular (LMAT) United States $0.622B 36.89
Surmodics (SRDX) United States $0.569B 108.08
MacroGenics (MGNX) United States $0.553B 0.00
Quanterix (QTRX) United States $0.529B 0.00
TG Therapeutics (TGTX) United States $0.491B 0.00
OraSure Technologies (OSUR) United States $0.461B 21.34
Owens & Minor (OMI) United States $0.410B 12.28
Meridian Bioscience (VIVO) United States $0.377B 11.76
Zynex (ZYXI) United States $0.362B 38.41
Utah Medical Products (UTMD) United States $0.349B 25.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.312B 0.00
BioLife Solutions (BLFS) United States $0.304B 93.44
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.223B 0.00
Vapotherm (VAPO) United States $0.167B 0.00
Rockwell Medical (RMTI) United States $0.156B 0.00
Cytosorbents (CTSO) United States $0.137B 0.00
Female Health (VERU) United States $0.134B 0.00
Fonar (FONR) United States $0.127B 8.93
Chimerix (CMRX) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
United-Guardian (UG) United States $0.084B 19.84
Nephros (NEPH) United States $0.068B 0.00
MTech Acquisition (KERN) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Senestech (SNES) United States $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.009B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00